Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma

Journal of Surgical Oncology

Volumn 100, Issue 3, 2009, Pages 199-204

  Ambrogi, Vincenzo ^a   Mineo, Davide ^a   Gatti, Antonio ^a   Pompeo, Eugenio ^a   Mineo, Tommaso C ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Extrapleural pneumonectomy; Malignant pleural mesothelioma; Quality of life; Thoracic surgery

Indexed keywords

CISPLATIN; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LUNG RESECTION; MALE; MALIGNANT MESOTHELIOMA; MORBIDITY; MULTIPLE CYCLE TREATMENT; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; SHORT FORM 36; ADJUVANT THERAPY; FOLLOW UP; MESOTHELIOMA; MIDDLE AGED; MORTALITY; PAIN; PATHOLOGY; PLEURA TUMOR;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COUGH; DYSPNEA; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PAIN; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 70249132960     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21261     Document Type: Article

References (27)

1. Peto J, DeCarli A, La Vecchia C, et al.: The European mesothelioma epidemic. Br J Cancer 1999;79:666-672.
2. Flores RM, Rusch VW: Diffuse malignant mesothelioma. In: Shields T, editor. General thoracic surgery. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 901-921.
3. Steele JP, Klabatsa A, Fennel DA, et al.: Prognostic factors in mesothelioma. Lung Cancer 2005;49S1:S49-S52.
4. Sugarbaker D, Flores R, Jaklitsch M, et al.: Resection margins, extrapleural nodal status and cell type determine postoperative long term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65. (Pubitemid 29022249)
5. Mineo TC, Ambrogi V, Pompeo E, et al.: The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma. Ann Thorac Surg 2008;85:1740-1746. (Pubitemid 351608195)
6. Weder W, Kestenholz P, Taverna C, et al.: Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 2004;22:3451-3457. (Pubitemid 41103650)
7. Rusch VW: Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997;9:367-372.
8. Mineo TC: La chirurgia della pleura. I tumori maligni della pleura. Atti del XVI Congresso Nazionale di Chirurgia Toracica. 1978; 201-223.
9. Schil PV: Malignant pleural mesothelioma: Staging systems. Lung Cancer 2005;49S1:S45-S48.
10. Rusch VW: A proposed new international TNM-staging system for malignant pleural mesothelioma: International Mesothelioma Interest Group. Chest 1995;108:1122-1128.
11. Common toxicity criteria manual. Version 2.0 1999.
12. Surveillance for respiratory disease in occupational setting. American Thoracic Society. Am Rev Resp Dis 1982;126:952-956.
13. Price DD, McGrath PA, Rafii A, et al.: The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
14. Dewys WD, Begg C, Lavin PT, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-497. (Pubitemid 10018703)
15. Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984;2:187-193.
16. Ware JE, Snow KK, Kosinski M: SF-361 Health Survery. Manual and interpretation guide. Lincoln, RI: Quality Metric Incorporated; 1993.
17. Apolone G, Mosconi P: The Italian SF-36 Health Survey: Translation, validation and norming. J Clin Epidemiol 1998;51:1025-1036. (Pubitemid 28527158)
18. Jones PW, Quirk FH, Baveystock CM, et al.: A self-complete measure of health status for chronic airflow limitation: The S. George's respiratory disease questionnaire. Am Rev Resp Dis 1992;145:1321-1327.
19. Carone M, Bertolotti G, Anchisi F, et al.: Il Saint George's Respiratory Questionnaire (SGRQ): La versione italiana. Rass Mal App Resp 1999;14:31-37.
20. Klemperer J, Ginsberg RJ: Mordibity and mortality after pneumonectomy. Chest Surg Clin North Am 1999;9:515-525.
21. Ilonen IK, Räsänen JV, Sihvo EI, et al.: Pneumonectomy: Postoperative quality of life and lung function. Lung Cancer 2007;58:397-402. (Pubitemid 350051510)
22. Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: Feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer core quality of life questionnaire and lung cancer module. J Clin Oncol 2004;22:3172-3180.
23. Bottomley A, Gaafar R, Manegold C, et al.: Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J Clin Oncol 2006;24:1435-1442. (Pubitemid 46622010)
24. Weder W, Stahel R, Bernhard J, et al.: Multicenter trial of neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-1202. (Pubitemid 47244366)
25. Balduyck B, Hendriks J, Lauwers P, et al.: Quality of life after lung cancer surgery: A prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy. J Thorac Oncol 2008;3:604-608. (Pubitemid 351787303)
26. Brunelli A, Socci L, Refai M, et al.: Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. Ann Thorac Surg 2007;84:410-416. (Pubitemid 47069207)
27. Muers MF, Stephens RJ, Fisher P, et al.: MS01 Trial Management Group. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): A multicentre randomised trial. Lancet 2008;371:1685-1694.